Hepatoma in an HBsAg carrier--seven years after perinatal infection.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 6283055)

Published in J Pediatr on July 01, 1982

Authors

R P Beasley, I S Shiao, T C Wu, L Y Hwang

Articles by these authors

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54

Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet (1996) 12.96

Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (1988) 7.05

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 6.03

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03

Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med (1975) 5.49

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet (1983) 4.01

The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07

Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia. Infect Immun (1972) 2.93

Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res (2000) 2.91

Isolation and characterization of a glucosamine-requiring mutant of Escherichia coli K-12 defective in glucosamine-6-phosphate synthetase. J Bacteriol (1971) 2.80

Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol (1985) 2.68

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest (2001) 2.61

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol (2008) 2.60

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet (1981) 2.56

The location and structure of double-strand DNA breaks induced during yeast meiosis: evidence for a covalently linked DNA-protein intermediate. EMBO J (1995) 2.54

Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol (1998) 2.50

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol (2011) 2.41

Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities. J Neurosci (2007) 2.31

Use of a recombination reporter insert to define meiotic recombination domains on chromosome III of Saccharomyces cerevisiae. Mol Cell Biol (1999) 2.22

Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 2.22

Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis (1983) 2.20

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol (2001) 2.13

Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther (2010) 2.13

HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol (1979) 2.06

Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery (1986) 1.98

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 1.94

The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86

Chemical characterization of a new surface antigenic polysaccharide from a mutant of Staphylococcus aureus. J Bacteriol (1971) 1.86

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res (2009) 1.79

Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens. J Clin Microbiol (1983) 1.78

Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res (2001) 1.75

Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74

Evaluation of three bacteriuria screening methods in a clinical research hospital. J Clin Microbiol (1985) 1.73

Comparison of lysis-centrifugation with lysis-filtration and a conventional unvented bottle for blood cultures. J Clin Microbiol (1984) 1.67

Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther (1999) 1.63

Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet (1975) 1.59

Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol (1983) 1.58

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg (1995) 1.58

Autoantibody response to heat shock protein 70 in patients with heatstroke. Am J Med (2001) 1.57

Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther (2001) 1.46

Problems in the current case definitions of congenital syphilis. J Pediatr (1996) 1.46

Improving DNA vaccine potency via modification of professional antigen presenting cells. Curr Opin Mol Ther (2003) 1.45

Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines. Am J Dis Child (1969) 1.43

Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis (1994) 1.41

Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Ther (2000) 1.41

HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS (1999) 1.38

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer (1998) 1.38

Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene (1993) 1.36

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA (2000) 1.33

Monoclonal antibodies to laminin reveal the heterogeneity of basement membranes in the developing and adult mouse tissues. J Cell Biol (1984) 1.33

Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol (2001) 1.32

Demonstration of papillomavirus capsid antigen in human conjunctival neoplasia. Arch Ophthalmol (1986) 1.28

The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev (1994) 1.23

Evaluation of a commercial kit for the routine detection of Clostridium difficile cytotoxin by tissue culture. J Clin Microbiol (1986) 1.23

Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol (1996) 1.22

Shigellosis in the United States: ten-year review of nationwide surveillance, 1964-1973. Am J Epidemiol (1976) 1.21

Experimental vaccine strategies for cancer immunotherapy. J Biomed Sci (1998) 1.18

Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer (1985) 1.18

Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue. Br J Cancer (1986) 1.17

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site. J Virol (2001) 1.16

A cluster of Acinetobacter Pneumonia in foundry workers. Ann Intern Med (1981) 1.16

A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res (1993) 1.12

Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer (1997) 1.11

Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol (1994) 1.11

Sexual behaviour, STDs and drug use in a crack house population. Int J STD AIDS (1999) 1.10

Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav (1991) 1.10

Low prevalence of rheumatoid arthritis in Chinese. Prevalence survey in a rural community. J Rheumatol Suppl (1983) 1.08

Immunohistochemical localization of entactin and laminin in mouse embryos and fetuses. Dev Biol (1983) 1.08

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol (2001) 1.08

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines. Vaccine (2000) 1.08

Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev (1996) 1.08

Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis (1984) 1.07

Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res (2001) 1.06

Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet (1988) 1.05

Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr (1989) 1.05

Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella. JAMA (1969) 1.04

Epidemiology of rubella on Taiwan. Am J Dis Child (1969) 1.03

Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology (1988) 1.02

Age distribution of antibody to reovirus-like agent in children in Taiwan. J Pediatr (1977) 1.02

A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses. Hum Mol Genet (1999) 1.02

Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis (1985) 1.02

Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis (1999) 1.01

Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis (1999) 1.01